Please use this identifier to cite or link to this item: https://scidar.kg.ac.rs/handle/123456789/8557
Title: Applying the molecular adsorbent recirculating system (MARS) in the treatment of acute liver failure (ALF) case report
Authors: Gavrilovic, Jagoda
Velickovic J.
Mijailovic Z.
Lazarević Ž.
Gavrilovic, Aleksandar
Tomovic, Marina
Journal: Serbian Journal of Experimental and Clinical Research
Issue Date: 1-Jun-2018
Abstract: © 2018, University of Kragujevac, Faculty of Science. All rights reserved. Acute liver failure (ALF) is a rare but life-threatening illness with multiple organ failure. The short-term mortality rate exceeded 80 % despite modern approaches in treatment. Drugs, infections by hepatic viruses and toxins are the most common causes of ALF. Progressive jaundice, coagulation disorder and hepatic encephalopathy are dominated as a clinical signs of the illness. We present a case of a 36-year-old Caucasian woman hospitalized in ICU due to yellow discoloration of the skin and sclera, severe disseminated coagulopathy and hemodynamic instability. ALF is developed due to Hepatitis B Virus infection, resulting in hepatic toxicity as well as coma. General condition rapidly improved after applying of Molecular Adsorbent Recirculating System (MARS), an extracorporeal liver support system based on albumin dialysis. It is relatively expensive treatment that is used for the patient with hepatic encephalopathy grade 3 or 4 in our institution. In conclusion, an early administration of MARS significantly reveals subjective and objective clinical improvement in the case we presented.
URI: https://scidar.kg.ac.rs/handle/123456789/8557
Type: article
DOI: 10.1515/SJECR-2017-0074
ISSN: 18208665
SCOPUS: 85052335559
Appears in Collections:Faculty of Medical Sciences, Kragujevac

Page views(s)

63

Downloads(s)

9

Files in This Item:
File Description SizeFormat 
10.1515-SJECR-2017-0074.pdf542.77 kBAdobe PDFThumbnail
View/Open


Items in SCIDAR are protected by copyright, with all rights reserved, unless otherwise indicated.